HUP9904345A3 - Oral contraceptive - Google Patents

Oral contraceptive

Info

Publication number
HUP9904345A3
HUP9904345A3 HU9904345A HUP9904345A HUP9904345A3 HU P9904345 A3 HUP9904345 A3 HU P9904345A3 HU 9904345 A HU9904345 A HU 9904345A HU P9904345 A HUP9904345 A HU P9904345A HU P9904345 A3 HUP9904345 A3 HU P9904345A3
Authority
HU
Hungary
Prior art keywords
oral contraceptive
contraceptive
oral
Prior art date
Application number
HU9904345A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24757747&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP9904345(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of HUP9904345A2 publication Critical patent/HUP9904345A2/hu
Publication of HUP9904345A3 publication Critical patent/HUP9904345A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HU9904345A 1996-07-26 1997-07-23 Oral contraceptive HUP9904345A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68678696A 1996-07-26 1996-07-26
PCT/US1997/012786 WO1998004268A1 (en) 1996-07-26 1997-07-23 Oral contraceptive

Publications (2)

Publication Number Publication Date
HUP9904345A2 HUP9904345A2 (hu) 2000-06-28
HUP9904345A3 true HUP9904345A3 (en) 2000-11-28

Family

ID=24757747

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904345A HUP9904345A3 (en) 1996-07-26 1997-07-23 Oral contraceptive

Country Status (17)

Country Link
EP (1) EP0917466B1 (hu)
JP (1) JP2000515888A (hu)
KR (1) KR100501021B1 (hu)
CN (1) CN1119999C (hu)
AT (1) ATE278406T1 (hu)
AU (1) AU713016B2 (hu)
BR (1) BR9710565A (hu)
CA (1) CA2261687A1 (hu)
DE (1) DE69731092T2 (hu)
DK (1) DK0917466T3 (hu)
ES (1) ES2229378T3 (hu)
HU (1) HUP9904345A3 (hu)
IL (1) IL127923A (hu)
NZ (1) NZ333862A (hu)
PT (1) PT917466E (hu)
SI (1) SI0917466T1 (hu)
WO (1) WO1998004268A1 (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
NZ517845A (en) * 1999-08-31 2004-12-24 Schering Ag Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
FR2801218B1 (fr) * 1999-11-23 2001-12-28 Hoechst Marion Roussel Inc Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
US7297688B2 (en) 2000-06-08 2007-11-20 Wyeth Starter kit for low dose oral contraceptives
EP1735056B1 (en) * 2004-03-19 2012-10-24 Warner Chilcott Company, LLC Extended cycle multiphasic oral contraceptive method
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
US8022053B2 (en) * 2004-11-02 2011-09-20 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol
US7704984B2 (en) * 2005-04-22 2010-04-27 Warner Chilcott Company, Llc Extended estrogen dosing contraceptive regimen
DE102005034498A1 (de) * 2005-07-20 2007-01-25 Grünenthal GmbH Orale Kontrazeption mit Trimegeston
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
WO2007106264A2 (en) * 2006-03-02 2007-09-20 Warner Chilcott Company, Inc. Extended cycle multiphasic oral contraceptive method
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2365103C3 (de) * 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
US4628051A (en) * 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4616006A (en) * 1983-09-26 1986-10-07 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
HU214598B (hu) * 1987-09-24 1998-04-28 Jencap Research Ltd Eljárás fogamzásgátló és hormonterápiához alkalmazható, ösztrogént és progesztint tartalmazó gyógyszerkészítmények előállítására
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
IE62665B1 (en) * 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
DE4313926A1 (de) * 1993-04-28 1994-11-03 Jenapharm Gmbh Pharmazeutisches Mehrphasenpräparat zur hormonalen Kontrazeption
NL9301562A (nl) * 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE4429374C1 (de) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente

Also Published As

Publication number Publication date
HUP9904345A2 (hu) 2000-06-28
IL127923A (en) 2004-07-25
PT917466E (pt) 2004-12-31
WO1998004268A1 (en) 1998-02-05
EP0917466A1 (en) 1999-05-26
DE69731092D1 (de) 2004-11-11
SI0917466T1 (en) 2005-02-28
AU3807697A (en) 1998-02-20
ATE278406T1 (de) 2004-10-15
CN1230888A (zh) 1999-10-06
BR9710565A (pt) 1999-08-17
KR100501021B1 (ko) 2005-07-18
IL127923A0 (en) 1999-11-30
AU713016B2 (en) 1999-11-18
DK0917466T3 (da) 2004-12-20
CA2261687A1 (en) 1998-02-05
CN1119999C (zh) 2003-09-03
JP2000515888A (ja) 2000-11-28
ES2229378T3 (es) 2005-04-16
EP0917466B1 (en) 2004-10-06
KR20000029537A (ko) 2000-05-25
DE69731092T2 (de) 2005-02-10
NZ333862A (en) 2000-08-25

Similar Documents

Publication Publication Date Title
EP1020193A4 (en) ORAL PREPARATION
GB2313783B (en) Oral 2-Methyl-Thieno-Benzodiazepine formulation
GB9613470D0 (en) Small solid oral dosage form
EP0682945A3 (de) Orale Retard-Präparation.
HK1017854A1 (en) Oral composition
GB9715972D0 (en) Oral compositions
AU3888597A (en) Oral contraceptive
HUP9904345A3 (en) Oral contraceptive
ZA976189B (en) Oral pharmaceutical combinations
GB9425941D0 (en) Oral composition
AU3961697A (en) Oral contraceptive
GB9618964D0 (en) Oral composition
AU2815897A (en) Oral contraceptive
AU135502S (en) Condom
AU2926897A (en) Oral contraceptive
GB9716124D0 (en) Condoms
GB9718616D0 (en) Oral vaccine
AU2926997A (en) Oral contraceptive
AU2926797A (en) Oral contraceptive
AU2746097A (en) Oral contraceptive
SG63838A1 (en) Oral composition
GB9608806D0 (en) Babsy condom
KR0107735Y1 (en) Condoms
PL317245A1 (en) Intraoral insert
GB9720312D0 (en) Oral hygiene system